Target intelligence / Profile preview

Natural killer cell cytotoxicity (against tumor cell) (NK cell cytotoxicity)

Target
NK cell cytotoxicity
Molecular classification
Other (Biological process, not a discrete molecular entity)
01

Overview

Natural killer cell-mediated cytotoxicity against tumor cells is a crucial effector process of the innate immune system, wherein NK cells recognize and selectively kill transformed (tumor) cells. This killing occurs primarily through two mechanisms: direct release of cytotoxic granules (containing perforin and granzymes) that induce apoptosis of target cells, and through engagement of death receptor pathways via ligands such as Fas ligand or TRAIL, resulting in programmed cell death of target cells[1][3][4]. NK cells play a central role in tumor immunosurveillance and are a key avenue in immunotherapy strategies, especially in cancer, though the term describes a process rather than a discrete therapeutic target[1][2][3][4][6].

Other names
NK cell-mediated cytotoxicityNK cell-mediated tumor lysisNK cell anti-tumor activity
02

Biological functions

Immune responseCell deathTumor surveillanceApoptosis
03

Disease associations

CancerInfectionInflammation
04

Safety considerations

Off-target cell death (damage to healthy cells)Cytokine release syndrome (with NK-based therapies or immune activation)
05

Biomarkers

NK cell activity (for patient monitoring)Expression of activating ligands on tumor cells (e.g., MICA/B, ULBP for NKG2D receptor)

Beyond the preview

Go deeper on Natural killer cell cytotoxicity (against tumor cell) (NK cell cytotoxicity).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell cytotoxicity (against tumor cell) (NK cell cytotoxicity).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call